Featured Research

from universities, journals, and other organizations

Synthetic Protein Thwarts HIV Attachment

Date:
January 15, 2001
Source:
Howard Hughes Medical Institute
Summary:
Researchers have synthesized a protein that jams the "grappling hook" that HIV uses to attach to target cells. The synthetic protein prevents a spring-loaded component of the grappling hook from snapping shut and drawing the virus to its target—one of the key steps in HIV infection. If HIV cannot fuse with the membrane on its target cell, infection cannot occur.

January 12, 2001 -— Researchers have synthesized a protein that jams the "grappling hook" that HIV uses to attach to target cells. The synthetic protein prevents a spring-loaded component of the grappling hook from snapping shut and drawing the virus to its target—one of the key steps in HIV infection. If HIV cannot fuse with the membrane on its target cell, infection cannot occur.

Related Articles


The researchers believe that the new protein may be useful in treating patients with drug-resistant HIV or those patients who experience side effects when taking antiviral medications. Howard Hughes Medical Institute (HHMI) investigator Peter S. Kim and his colleagues at the Whitehead Institute for Biomedical Research at MIT reported on the new anti-HIV protein in a research article published online on January 12, 2001, by the journal Science.

Development of the HIV-inhibiting protein, called 5-Helix, is based on earlier studies that showed that HIV uses a spring-loaded mechanism to attach to T cells, its primary targets in the immune system. In attaching to T cells, HIV first uses a protein called gp120 to recognize the CD4 receptor on the surface of a T cell. Once gp120 recognizes CD4, an HIV attachment protein called gp41 launches a harpoon-like component into the T cell’s membrane. Next, gp41’s spring mechanism snaps shut—forming what is known as the "trimer of hairpins," (named for its triple helical, u-shaped protein structure)—and draws the virus to the T cell like a grappling hook. The virus can then fuse its membrane with the T cell’s membrane.

In previous studies, a research team led by Kim and a second that included HHMI investigators Stephen C Harrison and Don Wiley at Harvard independently solved the structure of gp41. Kim's group focused on deep pockets in the molecule that looked to be excellent targets for inhibitory molecules. Last year, Kim's team identified D-peptide inhibitors of HIV infection that bound solely to the pocket, laying the groundwork for the potential development of "orally bioavailable inhibitors of HIV entry," said Kim. In addition, Harrison and HHMI investigator Stuart L. Schreiber created a library of compounds that fit into the pocket, when attached to a longer peptide, to block the action of gp41.

Other research on gp41 inhibitors has also shown that synthetic peptides could be created to bind to the grappling hook end of gp41 nearest the target cell—called the N-terminal end. In fact, such peptides have proven to be potent inhibitors of HIV, and one is currently in clinical trials.

Kim and his colleagues wanted to test the idea that protein inhibitors that bind to the C-terminal end of gp41—the end nearest the virus—could also be potent inhibitors of HIV infection by stopping the closing of the trimer-of-hairpins. To test this hypothesis, they synthesized 5-Helix, a small protein designed to bind to the C-terminal region, and looked at whether it could jam gp41 in cell culture.

"We really didn't know whether binding to the C-terminal region would actually stop the virus," said Kim. "So, we were pleasantly surprised to find that not only did it inhibit the virus, but it did so quite effectively. What’s more, we were very pleased to find that 5-Helix was capable of inhibiting a wide range of HIV isolates."

Analyzing the structure of the C-terminal region of gp41 in many versions of HIV, Kim and his colleagues found that, although there is variability in the region, the "face" of the C-terminal helix that actually interacts with 5-Helix is highly conserved among the different viral strains.

According to Kim, the 5-Helix molecule is stable, and is therefore likely to be resistant to degradation by the body’s enzymes. This is one reason why Kim believes that 5-Helix may be a good candidate for becoming an injectable anti-HIV therapy. Also, he said, the molecule can be altered—for instance, making it larger to reduce its elimination in the kidneys—without diminishing its ability to jam gp41. And carbohydrate molecules could also be added to the molecule to help shield it from the immune system, he added.

Kim foresees 5-Helix or its molecular cousins proving to be effective as "salvage therapies" to treat HIV patients who are suffering side effects from other drugs, or in whom HIV has mutated to become drug resistant. The durability of 5-Helix and its effectiveness bode well for rapid progress toward a therapy, he said.

"I think we are only a few steps away from testing in monkeys—for which good models of HIV infection exist—to determine whether 5-Helix or a derivative can reduce the viral load in the bloodstream," Kim said.

Other clinically important viruses also use similar trimer-of-hairpins proteins in infection, and a similar approach to inhibiting attachment might also work against them. "Work from our lab and from Don Wiley's lab has shown that the influenza and Ebola viruses use a similar mechanism, and we have recently shown that the human respiratory syncytial virus also uses the trimer-of-hairpins motif. All of these viruses are significant threats to human health, and we are hopeful that our approach to HIV inhibition can be broadly effective against them as well," said Kim.


Story Source:

The above story is based on materials provided by Howard Hughes Medical Institute. Note: Materials may be edited for content and length.


Cite This Page:

Howard Hughes Medical Institute. "Synthetic Protein Thwarts HIV Attachment." ScienceDaily. ScienceDaily, 15 January 2001. <www.sciencedaily.com/releases/2001/01/010111194307.htm>.
Howard Hughes Medical Institute. (2001, January 15). Synthetic Protein Thwarts HIV Attachment. ScienceDaily. Retrieved December 19, 2014 from www.sciencedaily.com/releases/2001/01/010111194307.htm
Howard Hughes Medical Institute. "Synthetic Protein Thwarts HIV Attachment." ScienceDaily. www.sciencedaily.com/releases/2001/01/010111194307.htm (accessed December 19, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Friday, December 19, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Kids Die While Under Protective Services

Kids Die While Under Protective Services

AP (Dec. 18, 2014) As part of a six-month investigation of child maltreatment deaths, the AP found that hundreds of deaths from horrific abuse and neglect could have been prevented. AP's Haven Daley reports. (Dec. 18) Video provided by AP
Powered by NewsLook.com
Dads-To-Be Also Experience Hormone Changes During Pregnancy

Dads-To-Be Also Experience Hormone Changes During Pregnancy

Newsy (Dec. 18, 2014) A study from University of Michigan researchers found that expectant fathers see a decrease in testosterone as the baby's birth draws near. Video provided by Newsy
Powered by NewsLook.com
Prenatal Exposure To Pollution Might Increase Autism Risk

Prenatal Exposure To Pollution Might Increase Autism Risk

Newsy (Dec. 18, 2014) Harvard researchers found children whose mothers were exposed to high pollution levels in the third trimester were twice as likely to develop autism. Video provided by Newsy
Powered by NewsLook.com
UN: Up to One Million Facing Hunger in Ebola-Hit Countries

UN: Up to One Million Facing Hunger in Ebola-Hit Countries

AFP (Dec. 17, 2014) Border closures, quarantines and crop losses in West African nations battling the Ebola virus could lead to as many as one million people going hungry, UN food agencies said on Wednesday. Duration: 00:52 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins